Wells Fargo’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.4M | Sell |
|
|||||
|
2025
Q1 | $92.4M | Sell |
|
|||||
|
2024
Q4 | $109M | Sell |
|
|||||
|
2024
Q3 | $183M | Buy |
|
|||||
|
2024
Q2 | $165M | Buy |
|
|||||
|
2024
Q1 | $122M | Buy |
|
|||||
|
2023
Q4 | $104M | Buy |
|
|||||
|
2023
Q3 | $95.9M | Sell |
|
|||||
|
2023
Q2 | $101M | Sell |
|
|||||
|
2023
Q1 | $120M | Sell |
|
|||||
|
2022
Q4 | $113M | Sell |
|
|||||
|
2022
Q3 | $118M | Sell |
|
|||||
|
2022
Q2 | $118M | Sell |
|
|||||
|
2022
Q1 | $159M | Buy |
|
|||||
|
2021
Q4 | $127M | Sell |
|
|||||
|
2021
Q3 | $163M | Sell |
|
|||||
|
2021
Q2 | $151M | Buy |
|
|||||
|
2021
Q1 | $127M | Sell |
|
|||||
|
2020
Q4 | $159M | Sell |
|
|||||
|
2020
Q3 | $202M | Buy |
|
|||||
|
2020
Q2 | $193M | Buy |
|
|||||
|
2020
Q1 | $109M | Buy |
|
|||||
|
2019
Q4 | $71.3M | Sell |
|
|||||
|
2019
Q3 | $53.2M | Sell |
|
|||||
|
2019
Q2 | $62M | Sell |
|
|||||
|
2019
Q1 | $129M | Buy |
|
|||||
|
2018
Q4 | $97.4M | Buy |
|
|||||
|
2018
Q3 | $79M | Sell |
|
|||||
|
2018
Q2 | $82.1M | Buy |
|
|||||
|
2018
Q1 | $77.7M | Sell |
|
|||||
|
2017
Q4 | $84.9M | Sell |
|
|||||
|
2017
Q3 | $114M | Sell |
|
|||||
|
2017
Q2 | $190M | Sell |
|
|||||
|
2017
Q1 | $163M | Sell |
|
|||||
|
2016
Q4 | $241M | Buy |
|
|||||
|
2016
Q3 | $249M | Sell |
|
|||||
|
2016
Q2 | $219M | Sell |
|
|||||
|
2016
Q1 | $253M | Sell |
|
|||||
|
2015
Q4 | $542M | Sell |
|
|||||
|
2015
Q3 | $528M | Sell |
|
|||||
|
2015
Q2 | $580M | Sell |
|
|||||
|
2015
Q1 | $529M | Sell |
|
|||||
|
2014
Q4 | $524M | Sell |
|
|||||
|
2014
Q3 | $533M | Sell |
|
|||||
|
2014
Q2 | $466M | Buy |
|
|||||
|
2014
Q1 | $483M | Buy |
|
|||||
|
2013
Q4 | $263M | Buy |
|
|||||
|
2013
Q3 | $199M | Buy |
|
|||||
|
2013
Q2 | $88.1M | Buy |
|